Habis, Ralph
Heck, Ashley
Bean, Paris
Probasco, John
Geocadin, Romergryko G.
Hasbun, Rodrigo
Venkatesan, Arun http://orcid.org/0000-0002-9335-7361
Article History
Received: 1 March 2024
Accepted: 2 July 2024
First Online: 31 July 2024
Conflicts of interest
: Rodrigo Hasbun receives research support and personal fees from BioFire Diagnostics. John Probasco receives personal compensation for activity as Editor-in-Chief of <i>The New England Journal of Medicine Journal Watch Neurology</i> and serves as site investigator for a treatment trial for autoimmune encephalitis sponsored by Genentech. Ralph Habis serves as study coordinator for a treatment trial for autoimmune encephalitis sponsored by Genentech. The other authors declare no conflicts of interest.
: This study was performed in line with the principles of the Declaration of Helsinki and was approved by the University of Texas and the Johns Hopkins School of Medicine Institutional Review Boards (IRB) (“Aseptic Meningoencephalitis in adults and children,” HSC-MS-08-0417, approval 05/11/2023; “Establishment of an encephalitis and seizure repository and database” IRB00083718, approval 11/30/2015; “Infectious and autoimmune encephalitis: a chart review” IRB00214450, approval 10/26/2021). The need for patient consent was waived by both IRBs.